Class Action Law Reporter

Text Size

Share this page on any of these social networking sites:
Share this page on any of these social networking sites: LinkedIn

 

Law Reporter Products

  • Abstract Sets
  • Court Documents
  • Injury Collections

Get More Info »

Search the Exchange »

April 2013

Case in Point

Consumers alleging Glaxo blocked generic version of Flonase settle

The consumers and third-party payers claim GlaxoSmithKline used unlawful FDA citizen petitions and other tactics to stall generic Flonase for almost two years, during which time they could have been paying lower prices on the generic drug. The drugmaker settled for $46 million. In re Flonase Antitrust Litig.

 

The American Association for Justice
777 6th Street, NW, Ste 200 • Washington, DC  20001 • 800.424.2725 or 202.965.3500

© 2014 AAJ